MediWound Ltd.
MDWD
$17.71
$0.362.08%
NASDAQ
| 06/30/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | 20.22M | 19.72M | 20.14M | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | 20.22M | 19.72M | 20.14M | |
| Cost of Revenue | -- | 17.59M | 17.27M | 17.47M | |
| Gross Profit | -- | 2.63M | 2.45M | 2.67M | |
| SG&A Expenses | -- | 13.14M | 11.93M | 11.31M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | 18.00K | 224.00K | 0.00 | |
| Total Operating Expenses | -- | 39.62M | 37.12M | 35.49M | |
| Operating Income | -- | -19.40M | -17.40M | -15.35M | |
| Income Before Tax | -- | -30.16M | -27.90M | -19.78M | |
| Income Tax Expenses | -- | 61.00K | 163.00K | 190.00K | |
| Earnings from Continuing Operations | -- | -30.22 | -28.06 | -19.97 | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | -30.22M | -28.06M | -19.97M | |
| EBIT | -- | -19.40M | -17.40M | -15.35M | |
| EBITDA | -- | -18.11M | -16.13M | -14.10M | |
| EPS Basic | -- | -3.07 | -2.90 | -2.16 | |
| Normalized Basic EPS | -- | -0.65 | -1.11 | -1.11 | |
| EPS Diluted | -- | -3.07 | -2.90 | -2.16 | |
| Normalized Diluted EPS | -- | -0.65 | -1.11 | -1.11 | |
| Average Basic Shares Outstanding | -- | 39.82M | 38.24M | 36.95M | |
| Average Diluted Shares Outstanding | -- | 39.82M | 38.24M | 36.95M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |